Harel Insurance and Financial
VC Fund
Tel Aviv, Israel
Harel Insurance and Financial is a VC fund in Tel Aviv focused on Software and Biotechnology. Harel Insurance Investments and Financial Services provide comprehensive financial and insurance solutions. The firm seeks to provide agents and customers with simpler, faster, and more personal service. It was founded in 1935 and is headquartered in Tel Aviv, Israel.
- Total investments:
- 38
- Last investment:
- Lead investor:
- 39%
Last updated:
For AI agents: llms.txt
Industries Harel Insurance and Financial invests in
Stages Harel Insurance and Financial invests in
Countries Harel Insurance and Financial invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $6.5M–$22M
- Series B
- $17M–$518M
- Series C
- $10M–$262M
Investment Focus
Industry
- Software 6 (16%)
- Biotechnology 6 (16%)
- FinTech 5 (13%)
- Health Care 4 (11%)
- Retail 3 (8%)
Stage
- Series B 7 (18%)
- Series C 6 (16%)
- Seed 5 (13%)
- Series A 5 (13%)
- Post-IPO Equity 5 (13%)
Country
- Israel 22 (58%)
- United States 9 (24%)
- Australia 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Tomer Goldberg
Vice President and Managing Director
|
Vice President and Managing Director | Total investments: 5 | Find email | |
|
Arik Peretz
CFO
|
CFO | Total investments: 0 | Find email | |
|
Michel Siboni
Co-CEO
|
Co-CEO | Total investments: 0 | Find email | |
|
Shimon Elkabetz
Co-CEO
|
Co-CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Undecimal Bio operates as a platform biotechnology company that develops targeted delivery mechanisms for small interfering RNA (siRNA) therapeutics. The company utilizes a proprietary platform that combines combinatorial chemistry libraries with transformer-based artificial intelligence to discover molecular conjugates capable of guiding genetic medicines to specified cells outside of the liver. This approach aims to circumvent traditional delivery constraints to expand the reach of RNA therapeutics into a broader range of therapeutic areas and human organs. | $18M / Seed / Oct 12, 2026 | ||
| With over 16GW of signed agreements, Ecoppia (TASE: ECPA) is a pioneer and world leader in robotic cleaning solutions for PV modules, keeping them clean, at year-round peak performance. Ecoppia's water-free, fully automated robotic solutions prevent soiling losses and potential damage, using advanced Business Intelligence capabilities.Remotely managed, Ecoppia's platform allows utility-scale solar sites to achieve optimal performance with minimal human intervention and lower LCOE. Ecoppia’s proprietary algorithms and robotic solutions make day-to-day O&M at solar sites safer, more efficient, and more reliable.Our clients enjoy the benefits of a cloud-based, data-driven platform, allowing them to reach their full potential while ensuring their constant growth and scalability.Publicly held and backed by prominent international investment funds, Ecoppia provides revolutionized solar ROIs for leading Tier1 energy conglomerates worldwide, cleaning millions of solar panels every month. | $21.7M / Post-IPO Equity / Jul 15, 2026 | ||
| Tomorrow.io develops a SaaS Weather intelligence platform that provides real-time weather forecasts. Fully customizable to any industry impacted by the weather, customers around the world including the NFL, Uber, Delta, Ford, National Grid, and more use Tomorrow.io to dramatically improve operational efficiency. Tomorrow.io was built from theground up to help teams predict the business impact of weather, streamline team communication and action plans, improve productivity, and optimize profit margins.Tomorrow.io has operations across North America, Latin America, Europe, and Asia. | $35M / Series F / May 18, 2026 | ||
| With over 16GW of signed agreements, Ecoppia (TASE: ECPA) is a pioneer and world leader in robotic cleaning solutions for PV modules, keeping them clean, at year-round peak performance. Ecoppia's water-free, fully automated robotic solutions prevent soiling losses and potential damage, using advanced Business Intelligence capabilities.Remotely managed, Ecoppia's platform allows utility-scale solar sites to achieve optimal performance with minimal human intervention and lower LCOE. Ecoppia’s proprietary algorithms and robotic solutions make day-to-day O&M at solar sites safer, more efficient, and more reliable.Our clients enjoy the benefits of a cloud-based, data-driven platform, allowing them to reach their full potential while ensuring their constant growth and scalability.Publicly held and backed by prominent international investment funds, Ecoppia provides revolutionized solar ROIs for leading Tier1 energy conglomerates worldwide, cleaning millions of solar panels every month. | $68.4M / Post-IPO Equity / Apr 08, 2026 | ||
| Advance is a fintech company that offers a payments platform for insurance premiums. | $8.6M / Seed / Feb 05, 2026 | ||
| Quantum Art is a developer of full-stack quantum computing system technology. Its technology aims to develop first ion trap quantum computer based on cutting-edge research from the Weizmann Institute of Science and to realize the potential of quantum computing. The company was founded in 2022 and is headquartered in Ness Tziona, Israel. | $100M / Series A / Dec 10, 2025 | ||
| Omnix Medical is dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacterial strains. Omnix is addressing an enormous and rapidly growing threat to public health, represented by millions worldwide, who suffer from infections associated with resistant bacteria. Omnix’s technologywill tilt the odds in the battle against resistant bacteria and improve the lives of many people worldwide. | $25M / Series C / Oct 15, 2025 | ||
| Fully automated diagnosis, interpretation & reporting of ultrasound examinations at the point of care. | $13M / Seed / Dec 27, 2023 | ||
| Tidhar is a dynamic international real estate group that initiates, builds, and markets residential, commercial, and industrial projects in Israel. | $107.2M / Corporate Round / Aug 01, 2023 | ||
| Lumi Finance is a fintech company that provides business funding. | $10.1M / Jul 21, 2023 | ||
| See all 38 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Harel Insurance and Financial invest in?
Harel Insurance and Financial invests primarily in Software, Biotechnology and FinTech startups, most often at Series B and Series C stage. Most of the 38 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Harel Insurance and Financial invest in?
Harel Insurance and Financial typically joins rounds of $6.5M–$22M at Seed, $17M–$518M at Series B and $10M–$262M at Series C. These are whole funding-round sizes, not Harel Insurance and Financial's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Harel Insurance and Financial took part in.
How do I contact Harel Insurance and Financial?
Public channels for Harel Insurance and Financial include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Harel Insurance and Financial?
The team at Harel Insurance and Financial includes Tomer Goldberg (Vice President and Managing Director), Arik Peretz (CFO) and Michel Siboni (Co-CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
